drugset

drugset / Trial / NCT00779181

A Dose-Ranging Study of the Safety and Efficacy of ADX415 in the Treatment of Essential Hypertension

NCT00779181 ↗

Phase 2 Completed 80 enrolled Addrenex Pharmaceuticals, Inc.

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine a safe and effective dose of ADX415 for the treatment of hypertension.

Timeline

Start: 2008-10
Primary completion: 2008-12
Completion: 2008-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	ADX415	Unknown	—	—

Indications